Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents.
Citation
Learning from toxicity patterns in phase I trials during the era of mechanism targeted agents. 2012, 23 (8):1934-6 Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mds116PubMed ID
22510374Type
ArticleLanguage
enISSN
1569-8041ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mds116
Scopus Count
Collections
Related articles
- Portal venous gas secondary to molecular targeted therapy.
- Authors: Alfaro MP, Cantera JE, Pérez IV
- Issue date: 2013 Aug
- Side effects of targeted therapies. Introduction.
- Authors: Eaby-Sandy B
- Issue date: 2014 Aug
- Reply: To PMID 23169717.
- Authors: Shinagare AB, Ramaiya NH
- Issue date: 2013 Aug
- Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience.
- Authors: Wheler JJ, Tsimberidou AM, Hong DS, Naing A, Falchook GS, Fu S, Moulder S, Stephen B, Wen S, Kurzrock R
- Issue date: 2012 Aug
- [Are targeted therapies better tolerated?].
- Authors: Stiefelhagen P
- Issue date: 2015 Apr 16